The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

Trump signed an executive order that he claims will force Big Pharma to lower prescription drug prices paid by Americans to match the prices paid in other countries.

If implemented successfully, the order could have profound effects on healthcare, leading to substantial cost savings in America.